MRNA – moderna, inc. (US:NASDAQ)
Stock Stats
News
Moderna (NASDAQ:MRNA) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Moderna (NASDAQ:MRNA) was given a new $18.00 price target on by analysts at UBS Group AG.
Moderna (NASDAQ:MRNA) had its price target raised by analysts at Leerink Partners from $15.00 to $18.00. They now have an "underperform" rating on the stock.
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Royal Bank Of Canada from $28.00 to $25.00. They now have a "sector perform" rating on the stock.
Form 4 Moderna, Inc. For: Dec 01 Filed by: Klinger Shannon Thyme
Form 4 Moderna, Inc. For: Dec 01 Filed by: Hoge Stephen
Form 4 Moderna, Inc. For: Nov 26 Filed by: Mock James M
Form 4 Moderna, Inc. For: Nov 26 Filed by: Klinger Shannon Thyme
Form 4 Moderna, Inc. For: Nov 26 Filed by: Hoge Stephen
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.